Point72 Asset Management’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,150,000
| Closed | -$5.65M | – | 1330 |
|
|
2021
Q3 | $5.65M | Sell |
1,150,000
-1,101,255
| -49% | -$5.41M | 0.02% | 594 |
|
|
2021
Q2 | $11.9M | Buy |
+2,251,255
| New | +$11.9M | 0.05% | 385 |
|
|
2019
Q2 | – | Sell |
-1,050,000
| Closed | -$7.47M | – | 1493 |
|
|
2019
Q1 | $7.47M | Sell |
1,050,000
-1,516,386
| -59% | -$10.8M | 0.03% | 407 |
|
|
2018
Q4 | $21.9M | Buy |
2,566,386
+122,686
| +5% | +$1.05M | 0.11% | 208 |
|
|
2018
Q3 | $48.9M | Buy |
2,443,700
+171,585
| +8% | +$3.44M | 0.2% | 104 |
|
|
2018
Q2 | $58.7M | Buy |
2,272,115
+235,515
| +12% | +$6.08M | 0.23% | 98 |
|
|
2018
Q1 | $48.7M | Sell |
2,036,600
-72,855
| -3% | -$1.74M | 0.2% | 118 |
|
|
2017
Q4 | $71.5M | Buy |
2,109,455
+1,259,290
| +148% | +$42.7M | 0.31% | 68 |
|
|
2017
Q3 | $18M | Buy |
850,165
+735,165
| +639% | +$15.6M | 0.08% | 238 |
|
|
2017
Q2 | $2.01M | Buy |
115,000
+62,700
| +120% | +$1.1M | 0.01% | 554 |
|
|
2017
Q1 | $915K | Sell |
52,300
-112,150
| -68% | -$1.96M | 0.01% | 659 |
|
|
2016
Q4 | $2.78M | Buy |
164,450
+33,950
| +26% | +$574K | 0.02% | 485 |
|
|
2016
Q3 | $2.14M | Sell |
130,500
-13,200
| -9% | -$217K | 0.02% | 516 |
|
|
2016
Q2 | $2.18M | Buy |
+143,700
| New | +$2.18M | 0.01% | 497 |
|
|
2015
Q3 | – | Sell |
-27,000
| Closed | -$708K | – | 875 |
|
|
2015
Q2 | $708K | Buy |
+27,000
| New | +$708K | ﹤0.01% | 578 |
|